Balchem Corporation (BCPC) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (36% profit margin, 14% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 9.67 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
SEC XBRL FY 2025 (10-K): 20.9% FCF Margin ($216.6M FCF) & 35.7% Gross Margin
Macro rate sensitivity & RSI-14 (50.4) create a -10 pt regime headwind
Even with a 70/100 (B-) score, BCPC faces multiple-compression risk if 35.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 33.2% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($170.17) or 200D SMA ($169.26) invalidates the momentum regime and cuts Target Base ($179.60) toward Bear Floor ($139.73).
Balchem Corporation (BCPC) surged +2.47% to $170.40, trading at 63% of its 52-week range ($147.18 – $183.9). High-quality cash engine (36% profit margin, 14% return on capital) with steady institutional support.
MONTVALE, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in Baird’s Global Industr
2026-10-26. The following slide deck was published by Balchem Corporation in conjunction with their 2026 Q3 earnings call.
As inflation accelerates, WD-40, Balchem, and Interparfums show pricing power and sales resilience despite rising chemical, freight, and logistics costs pressuring margins.
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $215 to $210.
The Q3 2026 release from Balchem landed with a clean headline. Record quarterly revenue of about US$291 million and adjusted earnings per share of US$1.57, both tied to stronger profitability, gave the report real substa
Moby summary of Balchem Corporation's Q3 2026 earnings call
Proprietary encapsulation tech is still penetrating its core markets, meaning growth can accelerate even without broader market expansion.
Record results driven by specialty nutrients and better-for-you food trends.
Balchem Q3 2026 results met estimates: EPS slightly beat, revenue just below consensus, with broad segment growth and strong cash flow.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +8.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BCPC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BCPC. Explore sector supply chains on /butterfly.
Across 270 tracked Materials securities in the Roarable RQD universe, Balchem Corporation (BCPC) ranks #12 by composite RQD confidence (70/100, grade B-) and #70 by equity capitalization ($5.41B). Within this direct 5-issuer industry benchmark cohort, BCPC leads on earnings valuation at 35.0x trailing P/E, while BCPC leads on capital efficiency and profitability with 14.0% ROIC and 35.7% gross margin. BCPC currently leads its immediate peer cohort in composite quantitative strength at 70/100 (B-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BCPC
ACTIVE
Balchem Corporation | B- | 70/100 | 35.0x | 35.7% | 14.0% | +2.47% | $5.41B | Benchmark Subject |
| CE Celanese Corporation | D | 44/100 | — | 20.5% | -10.7% | -1.08% | $5.30B | /ce-vs-bcpc → |
| SXT Sensient Technologies Corporation | C- | 60/100 | 41.6x | 33.5% | 8.8% | -0.05% | $5.60B | /sxt-vs-bcpc → |
| HXL Hexcel Corporation | D+ | 52/100 | 55.0x | 23.0% | 6.2% | +1.97% | $6.02B | /hxl-vs-bcpc → |
| MEOH Methanex Corporation | D | 51/100 | — | — | — | -1.24% | $4.86B | /meoh-vs-bcpc → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Balchem Corporation (BCPC) reported GAAP revenue of $1.04B (+8.8% vs. FY2024 revenue of $953.7M , and +12.4% cumulative change since FY2023) , GAAP net income of $154.8M, operating cash flow of $216.6M, and free cash flow of $216.6M (+19.0% YoY). On the balance sheet, BCPC closed FY2025 with $1.69B in total assets against $0 in total debt (Altman Z-Score: 9.67, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.04B | $154.8M | $216.6M | $216.6M | $1.69B | — |
| FY2024 (FY) | 2024-12-31 | $953.7M | $128.5M | $182.0M | $182.0M | $1.58B | — |
| FY2023 (FY) | 2023-12-31 | $922.4M | $108.5M | $183.8M | $183.8M | — | — |
As of 2026-11-01, Balchem Corporation (NASDAQ: BCPC) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $170.40 (+2.47% 1D, market cap $5.41B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 15/20. Across 270 tracked Materials issuers, BCPC ranks #12 in composite RQD confidence.
Within the Materials sector (Major Chemicals), BCPC carries a Roarable B- (70/100 RQD), trailing P/E of 35.0x, gross margin of 35.7%, and ROIC of 14.0%. By comparison, CE (Celanese Corporation) holds a D grade (44/100 RQD, P/E N/A, ROIC -10.7%, cap $5.30B) and SXT (Sensient Technologies Corporation) posts a C- grade (60/100 RQD, P/E 41.6x, ROIC 8.8%, cap $5.60B). Among the 5-stock peer group, BCPC leads on earnings multiple (35.0x) while BCPC leads on capital efficiency (14.0% ROIC).
Per BCPC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000009326), Balchem Corporation generated $1.04B in revenue (+8.8% YoY), $154.8M in net income, and $216.6M in free cash flow against $1.69B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (36% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
BCPC last traded at $170.40 (+2.47% on volume of 196,229 shares), positioning the stock +0.14% above its 50-day simple moving average ($170.17) and +0.67% above its 200-day simple moving average ($169.26). Across its 52-week range of $147.18 to $183.90, BCPC sits at the 63.2% percentile with a 14-day RSI of 50.4 (NEUTRAL RANGE) and an implied next-earnings move of ±4.6% ($162.56 to $178.24).
Why BCPC Stock surged +2.47% Today — RQD Quant Desk Flash. High-quality cash engine (36% profit margin, 14% return on capital) with steady institutional support.